Skip to content
GreenVista Online

Individuals Coming Off Anti-Obesity Injections Put On Weight Four Times Faster Compared to People Using Diet and Exercise

Image of pharmaceutical injection and weighing machine
Weight management involves long-term strategies.

Fresh analysis reveals that individuals who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens.

Findings released in a prominent medical journal demonstrates that while obese individuals frequently drop about a fifth of their body weight while undergoing treatment, the weight returns at an average rate of 0.8 kg per month after stopping.

"Individuals buying such treatments need to be aware of the risk of rapid weight regain when the medication concludes," warns expert Dr. Susan Jebb.

That rate of recovery means a reversion to starting mass within about one and a half years.

Weighing Therapies

The research, which reviewed 37 of trials involving thousands of patients, compared the outcomes of the injectable medications with older methods.

The team point out that people who shed pounds through lifestyle changes alone typically have a slower creep back—perhaps 0.1 kg a month—once they finish.

Explaining the Quick Regain

Experts believe the way of the jabs is key to understanding the heightened rebound.

The injections mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous GLP-1, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication results in hunger is unsuppressed, making binge eating far more likely."

A Chronic Disease?

Medical guidelines suggest the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians say that, due to the significant potential of relapse, the therapy is often ongoing.

This perspective is supported by pharmaceutical companies, who say that the results "highlight the long-term character of obesity," comparing it to managing diseases like high blood pressure.

User Accounts

Individuals who have come off the jabs describe a powerful resurgence of appetite.

"It was like a trigger flipping and you're instantly starving," described one woman.

This difficulty is compounded if individuals have not adopted lasting lifestyle or habit modifications during treatment.

Significant Interest

Figures indicate that a significant number of adults in the UK have used these injections in the past year, with desire continuing to grow.

  • Adoption is higher among females than men.
  • The middle-aged age group shows the highest usage rates.
  • Many obtain the drugs through private prescriptions rather than public health services.

In conclusion, researchers emphasize that while the jabs are potent tools for shedding pounds, they are not a standalone cure and maintained weight loss likely depends on combined lifestyle changes.

MP
The writer

Mary Perez

Milieu-expert en duurzaamheidsadviseur, schrijft over eco-vriendelijk wonen en groene technologie.

GreenVista Online

Type to search articles.